HeartSciences Inc. has announced the grant of a foundational patent by the United States Patent and Trademark Office (USPTO), which covers the estimation of echocardiography parameters indicative of heart function using an ECG. This patent is critical for the diagnosis and early detection of heart disease. The newly granted patent further expands HeartSciences' extensive patent portfolio, which now includes 10 US patents and 34 international patents across key global markets. The company believes this development reinforces its position as a leader in the rapidly growing AI-ECG field.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.